HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term outcome of renal transplantation in focal glomerulosclerosis.

AbstractINTRODUCTION:
Focal segmental glomerulosclerosis (FSGS) has a tendency to recur frequently after kidney transplantation. We evaluated 12 cases to examine the incidence and long-term outcomes of recurrent FSGS.
MATERIALS AND METHODS:
Twelve patients with renal failure caused by FSGS received kidney allografts from living related donors. Tacrolimus or cyclosporine was used in combination with prednisolone and azathioprine or mycophenolate mofetil.
RESULTS:
The mean graft survival was 87.4 +/- 46.8 months. The graft survival rates in FSGS recipients were at 1 year, 100%; 5 years, 79.6%; 10 years, 68.2%. Two out of four recipients experienced graft loss due to chronic rejection. The other two out of four recipients with graft loss displayed severe proteinuria diagnosed as recurrence of FSGS. To treat recurrent FSGS, plasma exchange was partially effective to reduce proteinuria.
CONCLUSION:
Our incidence of recurrent FSGS is 16.7% with graft survivals at 5 and 10 years of 79.6% and 68.2%, respectively. The recurrence of FSGS happened after scheduled reductions in immunosuppressants. Careful observation is required with maintenance of immunosuppression in these patients.
AuthorsK Akioka, M Okamoto, Y Wakabayashi, S Nobori, S Ogino, H Ushigome, K Uryuhara, S Kaihara, N Yoshimura
JournalTransplantation proceedings (Transplant Proc) Vol. 38 Issue 9 Pg. 2819-22 (Nov 2006) ISSN: 0041-1345 [Print] United States
PMID17112838 (Publication Type: Journal Article)
Topics
  • Biopsy
  • Family
  • Female
  • Follow-Up Studies
  • Glomerulosclerosis, Focal Segmental (pathology, surgery)
  • Graft Survival
  • Humans
  • Kidney Transplantation (physiology)
  • Living Donors
  • Male
  • Transplantation, Homologous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: